Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Narjust Duma, MD


Medical Oncology

Make an Appointment

Physician

  • Associate Director, Cancer Care Equity Program
  • Physician
  • Assistant Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Cancer health disparities
  • Lung cancer in women
  • Lung cancer survivorship
  • Quality of life and symptom's control
  • Thoracic malignancies

Contact Information

  • Fax617-632-5786

Bio

Dr. Narjust Duma is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine residency in Rutgers New Jersey Medical School and fellowship at the Mayo Clinic in Rochester, Minnesota where she was the chief fellow from 2018-2019.

Dr. Duma's clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine. She received many awards including the 2018 Resident of the Year Award by the National Hispanic Medical Association, the Mayo Brothers Distinguished Fellowship award and the 2020 Rising Star award by the LEAD national conference for women in hematology and oncology.

In addition, Dr. Duma founded the Duma Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine and medical education. The laboratory long-term goals are to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations. Members of the Duma Lab are agents of change.

Board Certification:

  • Internal Medicine, 2016
  • Medical Oncology, 2019

Fellowship:

  • Fred Hutchinson Cancer Research Center, Research
  • Mayo Clinic, Hematology/Medical Oncology

Residency:

  • Rutgers University - New Jersey Medical School

Medical School:

  • Universidad Catolica Nordestana

Research

Left Out: Disparities in Access to Care Among Foreign-Born Populations and Implications for Hospital-Based Studies. Am J Gastroenterol. 2022 Mar 23.
View in: PubMed

Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer Prostatic Dis. 2022 Mar 19.
View in: PubMed

With one eye on the future. Cancer Cell. 2022 Mar 14; 40(3):221-225.
View in: PubMed

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer. JAMA Netw Open. 2022 03 01; 5(3):e224304.
View in: PubMed

HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America. JCO Glob Oncol. 2022 03; 8:e2100251.
View in: PubMed

Immune checkpoint inhibitors and timing of administration. Lancet Oncol. 2022 02; 23(2):e56.
View in: PubMed

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Netw Open. 2022 01 04; 5(1):e2142046.
View in: PubMed

Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer. JCO Glob Oncol. 2022 Jan; 8:e2100153.
View in: PubMed

Women Oncologists' Perceptions and Factors Associated With Decisions to Pursue Academic vs Nonacademic Careers in Oncology. JAMA Netw Open. 2021 12 01; 4(12):e2141344.
View in: PubMed

COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. JAMA Oncol. 2021 12 01; 7(12):1882-1890.
View in: PubMed

Baby Steps in the Right Direction: Toward a Parental Leave Policy for Gastroenterology Fellows. Am J Gastroenterol. 2021 11 01; 116(11):2300.
View in: PubMed

Re: "The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality" by Signore et al. J Womens Health (Larchmt). 2021 09; 30(9):1362-1363.
View in: PubMed

Professional Address during Obstetrics and Gynecology Grand Rounds Introductions: Setting the Stage, Setting the Standard. J Surg Educ. 2021 Nov-Dec; 78(6):1930-1937.
View in: PubMed

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 09; 26(9):779-786.
View in: PubMed

Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer. Clin Pract. 2021 Jul 06; 11(3):441-454.
View in: PubMed

Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study. J Womens Health (Larchmt). 2021 Jun 24.
View in: PubMed

Sociodemographic disparities in the management of advanced lung cancer: a narrative review. J Thorac Dis. 2021 Jun; 13(6):3772-3800.
View in: PubMed

COVID-19 and Global Oncology: A Year in Review. JCO Glob Oncol. 2021 05; 7:797-801.
View in: PubMed

It Can Wait. Oncologist. 2021 05; 26(5):439-440.
View in: PubMed

#LatinasInMedicine: Using the Hashtag to Build Community in Medicine. J Grad Med Educ. 2021 Jun; 13(3):332-334.
View in: PubMed

Care without a compass: Including patients with cancer in COVID-19 studies. Cancer Cell. 2021 07 12; 39(7):895-896.
View in: PubMed

Videoconferencing Etiquette: Promoting Gender Equity During Virtual Meetings. J Womens Health (Larchmt). 2021 04; 30(4):460-465.
View in: PubMed

Evaluating Bias in Speaker Introductions at the American Society for Radiation Oncology Annual Meeting. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):303-311.
View in: PubMed

Evaluating Speaker Introductions at the American Society for Radiation Oncology Annual Meeting. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1400-1401.
View in: PubMed

Lung-cancer researchers and clinicians must pay more attention to women. Nature. 2020 11; 587(7834):S13.
View in: PubMed

Assessing vitamin D and mammographic breast density in Alaskan women. Clin Pract. 2020 Oct 15; 10(4):1253.
View in: PubMed

The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America. Cancer Cell. 2020 11 09; 38(5):605-608.
View in: PubMed

Oncology training in Latin America: are we ready for 2040? Lancet Oncol. 2020 10; 21(10):1267-1268.
View in: PubMed

The Dragon. Oncologist. 2020 10; 25(10):903-904.
View in: PubMed

Leveraging Social Media for Cardio-Oncology. Curr Treat Options Oncol. 2020 08 13; 21(10):83.
View in: PubMed

Unconscious Bias in Speaker Introductions at a Surgical Oncology Meeting: Hierarchy Reigns Over Gender. Ann Surg Oncol. 2020 Oct; 27(10):3754-3761.
View in: PubMed

Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 2020 Sep; 20(6):1115-1122.
View in: PubMed

Cancer Care for All? Tales of Caring for Undocumented Patients with Cancer. Oncologist. 2020 07; 25(7):552-554.
View in: PubMed

Pulmonary Complications Secondary to Immune Checkpoint Inhibitors. Int J Chronic Dis. 2020; 2020:4928648.
View in: PubMed

Osimertinib-Induced Cardiomyopathy. JACC Case Rep. 2020 Apr; 2(4):641-645.
View in: PubMed

Gender differences in publication rates in oncology: Looking at the past, present, and future. Cancer. 2020 06 15; 126(12):2759-2761.
View in: PubMed

It Is Time to Talk About Fertility and Immunotherapy. Oncologist. 2020 04; 25(4):277-278.
View in: PubMed

Reply to On the proportion of male breast cancer among all breast cancers. Cancer. 2020 01 01; 126(9):2034-2035.
View in: PubMed

Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference. J Clin Oncol. 2019 12 20; 37(36):3538-3545.
View in: PubMed

Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 2020 01 01; 126(1):26-36.
View in: PubMed

Primary neuroendocrine carcinoma of the brain. BMJ Case Rep. 2019 Sep 18; 12(9).
View in: PubMed

Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 05; 21(3):e115-e129.
View in: PubMed

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019 08; 94(8):1623-1640.
View in: PubMed

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol. 2019 Jul 01; 5(7):1008-1019.
View in: PubMed

Establishing a Mutually Respectful Environment in the Workplace: A Toolbox for Performance Excellence. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:e219-e226.
View in: PubMed

The State of Cancer Care in Venezuela. J Glob Oncol. 2019 05; 5:JGO1900031.
View in: PubMed

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal? Oncologist. 2019 11; 24(11):e1148-e1155.
View in: PubMed

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials. Oncologist. 2019 01; 24(1):96-102.
View in: PubMed

Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide. Case Rep Hematol. 2018; 2018:9615834.
View in: PubMed

Commentary: Race and Ethnicity in Biomedical Research - Classifications, Challenges, and Future Directions. Ethn Dis. 2018; 28(4):561-564.
View in: PubMed

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2(4):387-391.
View in: PubMed

Narjust Duma on How Gender Affects the Tolerability of Immunotherapy. Oncology (Williston Park). 2018 07 15; 32(7):332-3.
View in: PubMed

Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer? Curr Oncol Rep. 2018 06 08; 20(8):63.
View in: PubMed

Exclusion of Male Patients in Breast Cancer Clinical Trials. JNCI Cancer Spectr. 2018 Apr; 2(2):pky018.
View in: PubMed

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018 05; 16(5):526-534.
View in: PubMed

Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials. Oncologist. 2018 09; 23(9):1076-1078.
View in: PubMed

Preventing Today's Survivors of Breast Cancer From Becoming Tomorrow's Cardiac Patients. J Oncol Pract. 2018 04; 14(4):213-214.
View in: PubMed

Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. J Oncol Pract. 2018 01; 14(1):e1-e10.
View in: PubMed

Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia. Case Rep Hematol. 2017; 2017:6803804.
View in: PubMed

Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years. Ann Gastroenterol. 2016 Jul-Sep; 29(3):325-31.
View in: PubMed

Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series. Hematol Oncol. 2017 Jun; 35(2):246-251.
View in: PubMed

Enlarging Pancreatic Schwannoma: A Case Report and Review of the Literature. Clin Pract. 2015 Nov 05; 5(4):793.
View in: PubMed

Bronchial-oesophageal fistula: a rare initial presentation of squamous cell carcinoma of the lung. BMJ Case Rep. 2015 Jun 10; 2015.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street
Newton, MA 02459
Get Directions

Ratings

Top